|
IDENTIFICATION AND USE OF miRNAs FOR DIFFERENTIATING MYELOGENOUS LEUKAEMIA CELLS |
|
Principal Investigator: O. VOINNET
|
|
The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukaemia.
Pour lire la suite, merci de vous identifier ou de vous inscrire dans la zone de droite... |
